News Column

EVZIO™ naloxone HCl injection Auto-Injector Now Available in the United States for the Emergency Treatment of Opioid Overdose

July 23, 2014



By a News Reporter-Staff News Editor at Biotech Week -- Kaleo, a privately-held pharmaceutical company headquartered in Richmond, Virginia, announced the United States (U.S.) commercial availability of EVZIO for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression. EVZIO is not a substitute for emergency medical care. EVZIO, approved by the U.S. Food and Drug Administration (FDA) on April 3, 2014, is the first and only naloxone product labeled for immediate administration by family members or caregivers.(1)

"Opioid overdose is a significant and growing public health concern in America and until now, there have been limited options available for the rapid administration of this potentially life-saving drug in non-healthcare settings," said Spencer Williamson, CEO of kaleo. "We are pleased to be able to make EVZIO available soon after receiving approval by the FDA."

EVZIO is now available in the United States by prescription. EVZIO should be administered as quickly as possible when an opioid overdose is suspected because prolonged respiratory depression may result in damage to the central nervous system or death. Because people experiencing an opioid overdose generally lose consciousness, in most cases, family members or caregivers will likely be the ones who administer EVZIO. EVZIO uses voice and visual cues to assist in guiding a user through the injection process. After administering EVZIO, emergency medical care should be immediately sought (see also Kaleo).

"EVZIO is the first and only FDA approved naloxone auto-injector specifically designed to be used by individuals without medical training," said Evan Edwards, kaleo's Vice President of Product Development. "Additionally, using kaleo's comprehensive human factors engineering process, EVZIO was designed and validated for use by family members and caregivers."

To better serve patients, kaleo offers patient assistance and savings programs through kaleo Cares. For more information about kaleo Cares, please visit www.kaleopharma.com/who-we-are/kaleo-cares/

Keywords for this news article include: Antidotes, Pharmaceuticals, Drugs, Kaleo, Therapy, Naloxone Hydrochloride, Government Agencies Offices and Entities.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC


For more stories covering the world of technology, please see HispanicBusiness' Tech Channel



Source: Biotech Week


Story Tools






HispanicBusiness.com Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters